0

    539938

    MIL

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Medico Intercontinental Limite Share Price Today

    Investment Returns

    Over 1 Month -13.48% Over 3 Months 7.74% Over 6 Months -26.40% Over 1 Year -30.88%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Medico Intercontinental Limite fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 28.00
    • P/E Ratio (TTM) 11.80
    • Beta 0.33
    • Book Value / share 40.85
    • Return on equity 6.88%
    • EPS (TTM) 2.18
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.42
    info icon alternate text

    Medico Intercontinental Limite Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 15.82
    Operating Expense 15.82
    Net Profit 0.42
    Net Profit Margin (%) 2.65
    Earnings Per Share (EPS) 0.42
    EBITDA 1.28
    Effective Tax Rate (%) 42.46
    Particulars DEC 2025 (Values in Cr)
    Revenue 12.75
    Operating Expense 12.71
    Net Profit 0.61
    Net Profit Margin (%) 4.78
    Earnings Per Share (EPS) 0.61
    EBITDA 1.40
    Effective Tax Rate (%) 27.38
    Particulars SEP 2025 (Values in Cr)
    Revenue 12.42
    Operating Expense 12.20
    Net Profit 0.59
    Net Profit Margin (%) 4.75
    Earnings Per Share (EPS) 0.59
    EBITDA 1.45
    Effective Tax Rate (%) 25.92
    Particulars JUN 2025 (Values in Cr)
    Revenue 13.47
    Operating Expense 12.97
    Net Profit 0.56
    Net Profit Margin (%) 4.15
    Earnings Per Share (EPS) 0.56
    EBITDA 1.35
    Effective Tax Rate (%) 24.32
    Particulars MAR 2025 (Values in Cr)
    Revenue 15.24
    Operating Expense 14.68
    Net Profit 0.53
    Net Profit Margin (%) 3.47
    Earnings Per Share (EPS) 0.53
    EBITDA 1.13
    Effective Tax Rate (%) 23.18
    Particulars MAR 2026 (Values in Cr)
    Revenue 54.46
    Operating Expense 53.69
    Net Profit 2.18
    Net Profit Margin (%) 4.00
    Earnings Per Share (EPS) 2.18
    EBITDA 5.48
    Effective Tax Rate (%) 29.80
    Particulars MAR 2025 (Values in Cr)
    Revenue 67.13
    Operating Expense 64.06
    Net Profit 2.57
    Net Profit Margin (%) 3.82
    Earnings Per Share (EPS) 2.57
    EBITDA 4.81
    Effective Tax Rate (%) 28.21
    Particulars MAR 2024 (Values in Cr)
    Revenue 44.04
    Operating Expense 41.83
    Net Profit 1.90
    Net Profit Margin (%) 4.31
    Earnings Per Share (EPS) 1.90
    EBITDA 3.02
    Effective Tax Rate (%) 27.86
    Particulars MAR 2023 (Values in Cr)
    Revenue 48.88
    Operating Expense 46.84
    Net Profit 1.70
    Net Profit Margin (%) 3.47
    Earnings Per Share (EPS) 1.70
    EBITDA 2.84
    Effective Tax Rate (%) 28.15
    Particulars MAR 2022 (Values in Cr)
    Revenue 39.25
    Operating Expense 37.60
    Net Profit 1.31
    Net Profit Margin (%) 3.33
    Earnings Per Share (EPS) 4.04
    EBITDA 2.45
    Effective Tax Rate (%) 28.41
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 48.65
    ROE % 10.80
    ROCE % 13.71
    Total Debt to Total Equity 0.23
    EBITDA Margin 9.14
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 45.03
    ROE % 9.16
    ROCE % 12.37
    Total Debt to Total Equity 0.11
    EBITDA Margin 8.73
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 41.19
    ROE % 13.41
    ROCE % 16.53
    Total Debt to Total Equity 0.25
    EBITDA Margin 7.57
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 38.89
    ROE % 27.95
    ROCE % 25.40
    Total Debt to Total Equity 0.81
    EBITDA Margin 7.16
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 29.35
    ROE % 32.45
    ROCE % 24.80
    Total Debt to Total Equity 1.44
    EBITDA Margin 7.10
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 38.66
    ROE % 6.88
    ROCE % 9.51
    Total Debt to Total Equity 0.19
    EBITDA Margin 7.15
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 36.10
    ROE % 5.40
    ROCE % 7.73
    Total Debt to Total Equity 0.05
    EBITDA Margin 6.86
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 34.30
    ROE % 8.10
    ROCE % 10.86
    Total Debt to Total Equity 0.20
    EBITDA Margin 5.81
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 23.55
    ROE % 18.73
    ROCE % 18.78
    Total Debt to Total Equity 0.79
    EBITDA Margin 6.24
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 19.51
    ROE % 20.89
    ROCE % 19.71
    Total Debt to Total Equity 1.16
    EBITDA Margin 6.09
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.68
    Total Assets 75.76
    Total Liabilities 75.76
    Total Equity 48.64
    Share Outstanding 1
    Price to Book Ratio 0.92
    Return on Assets (%) 6.67
    Return on Capital (%) 7.71
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 3.36
    Total Assets 56.04
    Total Liabilities 56.04
    Total Equity 45.03
    Share Outstanding 1
    Price to Book Ratio 1.10
    Return on Assets (%) 7.04
    Return on Capital (%) 7.91
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 6.78
    Total Assets 58.87
    Total Liabilities 58.87
    Total Equity 41.18
    Share Outstanding 1
    Price to Book Ratio 2.42
    Return on Assets (%) 6.12
    Return on Capital (%) 7.86
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.86
    Total Assets 31.92
    Total Liabilities 31.92
    Total Equity 12.63
    Share Outstanding 0
    Price to Book Ratio 2.47
    Return on Assets (%) 9.70
    Return on Capital (%) 14.57
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.51
    Total Assets 30.64
    Total Liabilities 30.64
    Total Equity 9.53
    Share Outstanding 0
    Price to Book Ratio 1.31
    Return on Assets (%) 8.40
    Return on Capital (%) 13.93
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.41
    Total Assets 58.77
    Total Liabilities 58.77
    Total Equity 38.66
    Share Outstanding 1
    Price to Book Ratio 0.92
    Return on Assets (%) 4.36
    Return on Capital (%) 4.95
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 2.40
    Total Assets 39.44
    Total Liabilities 39.44
    Total Equity 36.09
    Share Outstanding 1
    Price to Book Ratio 1.10
    Return on Assets (%) 4.80
    Return on Capital (%) 5.12
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 4.94
    Total Assets 44.37
    Total Liabilities 44.37
    Total Equity 34.29
    Share Outstanding 1
    Price to Book Ratio 2.42
    Return on Assets (%) 3.84
    Return on Capital (%) 4.66
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.28
    Total Assets 17.71
    Total Liabilities 17.71
    Total Equity 7.65
    Share Outstanding 0
    Price to Book Ratio 2.47
    Return on Assets (%) 7.40
    Return on Capital (%) 9.47
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.11
    Total Assets 16.42
    Total Liabilities 16.42
    Total Equity 6.34
    Share Outstanding 0
    Price to Book Ratio 1.31
    Return on Assets (%) 7.27
    Return on Capital (%) 10.71
    Particulars MAR 2025 (Values in Cr)
    Net Income 6.97
    Cash from Operations -5.29
    Cash from Investing -2.18
    Cash from Financing 8.62
    Net change in Cash -0.67
    Free Cash Flow -3.29
    Particulars MAR 2024 (Values in Cr)
    Net Income 5.43
    Cash from Operations 6.87
    Cash from Investing -8.53
    Cash from Financing -0.45
    Net change in Cash -3.42
    Free Cash Flow 8.11
    Particulars MAR 2023 (Values in Cr)
    Net Income 4.94
    Cash from Operations -8.80
    Cash from Investing -5.38
    Cash from Financing 20.40
    Net change in Cash 4.92
    Free Cash Flow -8.38
    Particulars MAR 2022 (Values in Cr)
    Net Income 4.23
    Cash from Operations 5.01
    Cash from Investing -1.29
    Cash from Financing -1.20
    Net change in Cash 1.35
    Free Cash Flow 5.22
    Particulars MAR 2021 (Values in Cr)
    Net Income 3.53
    Cash from Operations 6.59
    Cash from Investing -0.94
    Cash from Financing -5.14
    Net change in Cash -0.26
    Free Cash Flow 6.80
    Particulars MAR 2025 (Values in Cr)
    Net Income 3.57
    Cash from Operations -5.78
    Cash from Investing -4.77
    Cash from Financing 10.57
    Net change in Cash -0.98
    Free Cash Flow -3.89
    Particulars MAR 2024 (Values in Cr)
    Net Income 2.62
    Cash from Operations 6.34
    Cash from Investing -6.64
    Cash from Financing -1.62
    Net change in Cash -2.54
    Free Cash Flow 6.37
    Particulars MAR 2023 (Values in Cr)
    Net Income 2.37
    Cash from Operations -11.29
    Cash from Investing -5.02
    Cash from Financing 20.63
    Net change in Cash 3.66
    Free Cash Flow -10.92
    Particulars MAR 2022 (Values in Cr)
    Net Income 1.82
    Cash from Operations 1.72
    Cash from Investing -0.79
    Cash from Financing 0.87
    Net change in Cash 1.16
    Free Cash Flow 1.78
    Particulars MAR 2021 (Values in Cr)
    Net Income 1.66
    Cash from Operations 5.91
    Cash from Investing -0.94
    Cash from Financing -4.51
    Net change in Cash -0.02
    Free Cash Flow 6.09
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 37.26 15.46 1.80 285.54 23.12 38.85
    BLISS GVS PHARMA LTD 465.70 37.50 4.14 4947.78 118.35 552.90
    CIPLA LTD 1469.00 33.16 3.44 118672.48 1165.55 1672.20
    FERMENTA BIOTECH LTD. 511.60 23.93 3.70 1505.69 256.40 518.45
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 37.26 26.06 4.80 285.54 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 520.40 23.33 4.06 1504.51 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8296.00 108.42 23.76 20740.00 7630.00 9850.00
    BLISS GVS PHARMA LTD 465.70 50.40 4.28 4947.78 118.35 552.90

    Medico Intercontinental Limite shareholding pattern

    Holding
    41.48%
    58.51%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Medico Intercontinental Limite Technicals Summary

    28.00 8.82 redarrow
    red-green-graph indicator
    3 Bearish
    13 Bullish
    • 5 Days 25.30
    • 26 Days 26.00
    • 10 Days 25.40
    • 50 Days 26.30
    • 12 Days 25.50
    • 100 Days 27.40
    • 20 Days 25.90
    • 200 Days 30.20
    25.65 PIVOT
    First Support 24.39 First Resistance 26.98 Second Support 23.06 Second Resistance 28.24 Third Support 21.80 Third Resistance 29.57
    RSI 48.51 ADX 39.81 MACD -0.49 Williams % R -70.27 Commodity Channel Index (CCI) -45.70
    Date 2026-08-03 Week 868.00 Same Day 616.00 Month 1181.00
    1 Year 0.33 3 Year 0.35
    Over 1 Month
    -13.48% down
    Over 1 Year
    -30.88% down
    Over 3 Months
    7.74% down
    Over 3 Years
    -28.33% down
    Over 6 Months
    -26.40% down
    Over 5 Years
    -12.47% down

    Medico Intercontinental Limite Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    23 Jun 2023 0.1 Final 23 Jun 2023 Equity shares

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Medico Intercontinental Ltd?

    Answer Field

    Medico Intercontinental Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 28.00 as on Aug 04 2026 03:30 PM.

    What is the Market Cap of Medico Intercontinental Ltd Share?

    Answer Field

    The market cap of Medico Intercontinental Ltd for NSE ₹ 0.00 & for BSE ₹ 28.00 as on Aug 04 2026 03:30 PM.

    What is the 52 Week High and Low of Medico Intercontinental Ltd?

    Answer Field

    The 52 Week High and Low of Medico Intercontinental Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 43.00 and ₹ 20.61.

    What is 1 year return for Medico Intercontinental Ltd?

    Answer Field

    The 1 year returns on the stock has been -30.88%.

    What is the P/E Ratio of Medico Intercontinental Ltd Share?

    Answer Field

    As on Aug 04 2026 03:30 PM the price-to-earnings (PE) ratio for Medico Intercontinental Ltd share is 11.80.

    What is the PB ratio of Medico Intercontinental Ltd Share?

    Answer Field

    As on Aug 04 2026 03:30 PM, the price-to-book (PB) ratio for Medico Intercontinental Ltd share is 40.85.

    How to Buy Medico Intercontinental Ltd Share?

    Answer Field

    You can trade in Medico Intercontinental Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Medico Intercontinental Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Medico Intercontinental Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Medico Intercontinental Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |